ResearcherSanguine Diagnostics And TherapeuticsActive in the last 2 years

Joshua James Souchek

Verified by NIH RePORTER profile ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on NIH RePORTER profile ID 10891734. Sources: NIH RePORTER.

Their work

Papers: 0
Trials: 0
Grants: 3
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2019: 2 grants · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 grant

Grants 3

Anti-MUC16 humanized antibody combination regimen for targeting metastasis in pancreatic cancer R44CA306744 ↗
Seromic Mucin Signature for the Early Diagnosis of Pancreatic Cancer R44CA224619 ↗
MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases R44DK117472 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Aaron R Sasson · 2 shared grants, 2019–2026 · strength 1.28
- Grant Anti-MUC16 humanized antibody combination regimen for targeting metastasis in pancreatic cancer R44CA306744 ↗
- Grant MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases R44DK117472 ↗
Ashu Shah · 1 shared grant, 2026 · strength 1.00
- Grant Anti-MUC16 humanized antibody combination regimen for targeting metastasis in pancreatic cancer R44CA306744 ↗
Wade M Junker · 2 shared grants, 2019 · strength 0.55
- Grant Seromic Mucin Signature for the Early Diagnosis of Pancreatic Cancer R44CA224619 ↗
- Grant MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases R44DK117472 ↗
Maneesh Jain · 2 shared grants, 2019 · strength 0.55
- Grant Seromic Mucin Signature for the Early Diagnosis of Pancreatic Cancer R44CA224619 ↗
- Grant MUC4/16 assay for the early diagnosis and management of benign and malignant pancreatic diseases R44DK117472 ↗
Sukhwinder Kaur · 1 shared grant, 2019 · strength 0.28
- Grant Seromic Mucin Signature for the Early Diagnosis of Pancreatic Cancer R44CA224619 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.